150 related articles for article (PubMed ID: 15078135)
1. Anti-cytokine therapy for the treatment of graft-versus-host disease.
Jacobsohn DA; Vogelsang GB
Curr Pharm Des; 2004; 10(11):1195-205. PubMed ID: 15078135
[TBL] [Abstract][Full Text] [Related]
2. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Jacobsohn DA; Vogelsang GB
Drugs; 2002; 62(6):879-89. PubMed ID: 11929336
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutics for the treatment of graft-versus-host disease.
Jacobsohn DA
Expert Opin Investig Drugs; 2002 Sep; 11(9):1271-80. PubMed ID: 12225248
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for graft-versus-host disease.
Jacobsohn DA
Expert Opin Emerg Drugs; 2003 Nov; 8(2):323-38. PubMed ID: 14661992
[TBL] [Abstract][Full Text] [Related]
5. [Role of monoclonal antibodies in the treatment of acute graft versus host disease].
Bay JO; Cabrespine A; Peffault de Latour R
Bull Cancer; 2007 Jan; 94(1):33-41. PubMed ID: 17237003
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
Swiatecka-Urban A
Paediatr Drugs; 2003; 5(10):699-716. PubMed ID: 14510627
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD.
Rager A; Frey N; Goldstein SC; Reshef R; Hexner EO; Loren A; Luger SM; Perl A; Tsai D; Davis J; Vozniak M; Smith J; Stadtmauer EA; Porter DL
Bone Marrow Transplant; 2011 Mar; 46(3):430-5. PubMed ID: 20498647
[TBL] [Abstract][Full Text] [Related]
9. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the treatment of graft-versus-host disease.
Iwasaki T
Clin Med Res; 2004 Nov; 2(4):243-52. PubMed ID: 15931364
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
Basić-Jukić N; Labar B
Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693
[TBL] [Abstract][Full Text] [Related]
12. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.
Racadot E; Milpied N; Bordigoni P; Cahn JY; Plouvier E; Lioure B; Lutz P; Wijdenes J; Herve P
Bone Marrow Transplant; 1995 May; 15(5):669-77. PubMed ID: 7670394
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic effects of interleukin-2 receptor antagonists against graft-versus-host disease following unrelated donor peripheral blood stem cell transplantation.
Fang J; Hu C; Hong M; Wu Q; You Y; Zhong Z; Li W; Zou P; Hu Y; Xia L
Biol Blood Marrow Transplant; 2012 May; 18(5):754-62. PubMed ID: 21963619
[TBL] [Abstract][Full Text] [Related]
14. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab.
Willenbacher W; Basara N; Blau IW; Fauser AA; Kiehl MG
Br J Haematol; 2001 Mar; 112(3):820-3. PubMed ID: 11260089
[TBL] [Abstract][Full Text] [Related]
15. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Rodriguez V; Anderson PM; Trotz BA; Arndt CA; Allen JA; Khan SP
Pediatr Blood Cancer; 2007 Aug; 49(2):212-5. PubMed ID: 16261610
[TBL] [Abstract][Full Text] [Related]
16. Intestinal graft-versus-host disease: mechanisms and management.
Takatsuka H; Iwasaki T; Okamoto T; Kakishita E
Drugs; 2003; 63(1):1-15. PubMed ID: 12487619
[TBL] [Abstract][Full Text] [Related]
17. Novel drugs for the prevention and treatment of acute GVHD.
Cutler C; Antin JH
Curr Pharm Des; 2008; 14(20):1962-73. PubMed ID: 18691107
[TBL] [Abstract][Full Text] [Related]
18. Chronic graft-versus-host disease: Pathogenesis and clinical management.
Pérez-Simón JA; Sánchez-Abarca I; Díez-Campelo M; Caballero D; San Miguel J
Drugs; 2006; 66(8):1041-57. PubMed ID: 16789791
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.
Wolff D; Steiner B; Hildebrandt G; Edinger M; Holler E
Curr Pharm Des; 2009; 15(17):1974-97. PubMed ID: 19519437
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
